Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2016 Filed Nov 21, 2016 21:24 UTC |
Innes Guy ArchibaldDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003845 · primary_doc.xml · derivative · entry 3 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:24 UTC |
Innes Guy ArchibaldDirector
|
Tax withholdingCommon Stock | 3,349 | $4.48 | $15,003.52 |
DisclosureSEC source: 0001078782-16-003845 · primary_doc.xml · nonDerivative · entry 2 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,230,154 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:24 UTC |
Innes Guy ArchibaldDirector
|
Exercise / conversionCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001078782-16-003845 · primary_doc.xml · nonDerivative · entry 1 Innes Guy Archibald · CIK 0001579377 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,233,503 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:20 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003844 · primary_doc.xml · derivative · entry 3 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Borlaug Limited Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · ownership.nature: The Option is held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issuable upon the exercise of the Option. Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issuable upon the exercise of the Option, except to the extent of his pecuniary interest. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:20 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Tax withholdingCommon Stock | 13,393 | $4.48 | $60,000.64 |
DisclosureSEC source: 0001078782-16-003844 · primary_doc.xml · nonDerivative · entry 2 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Borlaug Limited Disclosed balance after: 38,113 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. F2 · ownership.nature: The shares of Common Stock are held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issued to Borlaug Limited upon the exercise of the Option. Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issued upon exercise of the Option, except to the extent of his pecuniary interest. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:20 UTC |
Micallef Jacob VincentChief Scientific Officer
|
Exercise / conversionCommon Stock | 20,000 | $3.00 | $60,000.00 |
DisclosureSEC source: 0001078782-16-003844 · primary_doc.xml · nonDerivative · entry 1 Micallef Jacob Vincent · CIK 0001651671 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Borlaug Limited Disclosed balance after: 51,506 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · ownership.nature: The shares of Common Stock are held directly by Borlaug Limited. Dr. Micallef is a controlling director of Borlaug Limited and has voting and dispositive control over the shares of Common Stock issued to Borlaug Limited upon the exercise of the Option. Dr. Micallef disclaims beneficial ownership of the shares of Common Stock issued upon exercise of the Option, except to the extent of his pecuniary interest. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:14 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003843 · primary_doc.xml · derivative · entry 3 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:14 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Tax withholdingCommon Stock | 13,393 | $4.48 | $60,000.64 |
DisclosureSEC source: 0001078782-16-003843 · primary_doc.xml · nonDerivative · entry 2 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,114,673 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 21:14 UTC |
Reynolds Cameron JohnDirector · President and CEO
|
Exercise / conversionCommon Stock | 20,000 | $3.00 | $60,000.00 |
DisclosureSEC source: 0001078782-16-003843 · primary_doc.xml · nonDerivative · entry 1 Reynolds Cameron John · CIK 0001340610 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,066 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:52 UTC |
Skaff HabibDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001078782-16-003789 · primary_doc.xml · derivative · entry 3 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2016-11-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:52 UTC |
Skaff HabibDirector
|
Tax withholdingCommon Stock | 2,791 | $4.30 | $12,001.30 |
DisclosureSEC source: 0001078782-16-003789 · primary_doc.xml · nonDerivative · entry 2 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,399 F1 · shares: Represents the aggregate number of shares of common stock retained by VolitionRx for cancellation as payment of the exercise price in a cashless exercise. No shares were sold by the Reporting Person or VolitionRx in such cashless exercise transaction. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:52 UTC |
Skaff HabibDirector
|
Exercise / conversionCommon Stock | 4,000 | $3.00 | $12,000.00 |
DisclosureSEC source: 0001078782-16-003789 · primary_doc.xml · nonDerivative · entry 1 Skaff Habib · CIK 0001620124 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2016 Filed Oct 6, 2016 16:31 UTC |
KRATOCHVIL DAVID MATTHEWChief Financial Officer
|
PurchaseCommon Stock | 10,000 | $5.00 | $50,000.00 |
DisclosureSEC source: 0001078782-16-003581 · primary_doc.xml · nonDerivative · entry 1 KRATOCHVIL DAVID MATTHEW · CIK 0001650670 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · shares: These shares were purchased by the reporting person in connection with an underwritten public offering by the Issuer. The offering closed on October 5, 2016. The reported sale price reflects the price at which the reporting person purchased the shares from the underwriters. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 20:27 UTC |
KRATOCHVIL DAVID MATTHEWChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001078782-16-003481 · primary_doc.xml · derivative · entry 1 KRATOCHVIL DAVID MATTHEW · CIK 0001650670 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2022-09-13 F1 · derivative.exercise_date: A total of 25,000 Options were granted on September 13, 2016 under the Company's 2015 Stock Incentive Plan. The Options vest in full twelve months from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.